2014
DOI: 10.1002/cmdc.201300428
|View full text |Cite
|
Sign up to set email alerts
|

A Cell‐Permeable Ester Derivative of the JmjC Histone Demethylase Inhibitor IOX1

Abstract: The 2-oxoglutarate (2OG)-dependent Jumonji C domain (JmjC) family is the largest family of histone lysine demethylases. There is interest in developing small-molecule probes that modulate JmjC activity to investigate their biological roles. 5-Carboxy-8-hydroxyquinoline (IOX1) is the most potent broad-spectrum inhibitor of 2OG oxygenases, including the JmjC demethylases, reported to date; however, it suffers from low cell permeability. Here, we describe structure–activity relationship studies leading to the dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
55
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 62 publications
(58 citation statements)
references
References 39 publications
(70 reference statements)
2
55
0
Order By: Relevance
“…Due to the poor cell permeability of IOX1, a series of 8-hydroxyquinoline derivatives has been designed. An n-octyl ester derivative of IOX1 was reported by Schiller et al, which showed not only high cell permeability but also high selectivity and even less toxicity with preserving cell viability (Schiller et al, 2014) (Table 2). Comparing the complex structures of KDM4A with IOX1 and the n-octyl ester derivative of IOX1 by docking, it was discovered that the KDM4A active site can accommodate IOX1 ester derivatives, but the length of the alkyl chain is likely to affect the binding affinity.…”
Section: Kdm4: a Subfamily Of Jmjc Domain-containing Protein Demethylmentioning
confidence: 93%
“…Due to the poor cell permeability of IOX1, a series of 8-hydroxyquinoline derivatives has been designed. An n-octyl ester derivative of IOX1 was reported by Schiller et al, which showed not only high cell permeability but also high selectivity and even less toxicity with preserving cell viability (Schiller et al, 2014) (Table 2). Comparing the complex structures of KDM4A with IOX1 and the n-octyl ester derivative of IOX1 by docking, it was discovered that the KDM4A active site can accommodate IOX1 ester derivatives, but the length of the alkyl chain is likely to affect the binding affinity.…”
Section: Kdm4: a Subfamily Of Jmjc Domain-containing Protein Demethylmentioning
confidence: 93%
“…5-carboxy-8-hydroxyquinoline (later named IOX1) ( Fig. 4) was initially identified in a large screen as a potent and somewhat specific inhibitor of the KDM4 family (King et al 2010;Hopkinson et al 2013), and was later derivatized to improve cell permeability (compound 5 [Schiller et al 2014]) ( Fig. 4) and specificity (Feng et al 2015), with a 2-1H-benzo[d ]imidazole substituted compound (6p) (Fig.…”
Section: Other Jmjc Inhibitorsmentioning
confidence: 99%
“…Further work on these compounds will be necessary to determine on-target toxicity and specificity for certain JmjC demethylases. More recently, 5-carboxy-8-hydroxyquinoline (IOX1) has been shown to inhibit a broad spectrum of JmjC demethylases by binding at the αKG binding pocket (87). Although IOX1 directly binds the αKG binding pocket to affect JmjC demethylase activity, it also chelates iron (II), which may produce negative effects on iron-dependent proteins (87).…”
Section: Targeting Jmjc Demethylases For Cancer Therapymentioning
confidence: 99%